The Relationship Between Sleep Disorders and Cytokine Levels Among Hemodialysis and Peritoneal Dialysis Patients
|ClinicalTrials.gov Identifier: NCT00172471|
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : December 21, 2005
Sleep disorders are common in patients with end-stage renal disease on both hemodialysis and peritoneal dialysis and are associated with significant medical, psychological and social disturbances. Numerous factors have been suggested as contributing to or associated with the high prevalence of sleep disturbance in this population.
Increasing evidence suggests that cytokines are involved in the regulation of sleep and wakefulness and that the communication between the sleep and the immune system is bi-directional. Blood-dialyzer or peritoneum-dialysate interaction during dialysis therapy has the potential to activate mononuclear cells leading to production of inflammatory cytokines. These cytokines are believed to play a significant role in dialysis-associated morbidity and mortality. Nevertheless, a cytokine overproduction may alter sleep pattern in chronic dialyzed patients, thus explaining the presence of sleep disorders in these patients. In the other way, sleep loss may have effects on immune process and secretion of cytokines in chronic dialyzed patients. The purpose of this study was to examine the relationship between quality of sleep and serum cytokine levels in hemodialysis and peritoneal dialysis patients.
|Condition or disease|
|Renal Failure Sleep Disorder Hemodialysis Peritoneal Dialysis|
|Study Type :||Observational|
|Observational Model:||Defined Population|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00172471
|Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital|
|Taipei, Taiwan, 100|
|Principal Investigator:||Jenq-Wen Huang, MD||Department of Internal Medicine, National Taiwan University Hospital|